The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes
Related Experiment Videos
Abstract:
Somatostatin (SRIF) inhibits vasoactive intestinal peptide (VIP)-stimulated cAMP accumulation in the GH4C1 strain of rat pituitary tumor cells, and this effect is responsible for SRIF inhibition of VIP-stimulated hormone release. In this study we examined the interaction between the SRIF receptor and adenylate cyclase in GH4C1 cell membranes. Maximal concentrations of VIP (50 nM) increased membrane adenylate cyclase activity 4.2-fold; half-maximal stimulation was observed with 0.75 nM VIP. SRIF noncompetitively inhibited the stimulatory effect of VIP, but it did not alter basal adenylate cyclase activity. The relative potencies of SRIF and two SRIF analogs as inhibitors of VIP-stimulated adenylate cyclase activity in membranes and of VIP-stimulated cAMP accumulation in intact cells were similar. Furthermore, the concentration of SRIF that caused half-maximal inhibition of adenylate cyclase activity (ED50 = 2.3 nM) was close to the equilibrium dissociation constant for SRIF (Kd = 0.40 nM) measured in membrane preparations in the presence of GTP. Therefore, SRIF inhibition of adenylate cyclase appears to be receptor mediated. As with receptors known to regulate adenylate cyclase by interaction with a guanine nucleotide regulatory subunit, SRIF receptor binding was decreased in the presence of guanine nucleotides. Addition of GTP (150 microM) or the nonhydrolyzable GTP analog guanyl-5'-yl-imidodiphosphate (100 microM) decreased the specific binding of [125I-Tyr1]SRIF to 31% and 13% of the control value, respectively. This decrease in specific binding was due entirely to decreased receptor affinity for SRIF. GTP (150 microM) increased the equilibrium dissociation constant for SRIF from 0.11 to 0.40 nM, whereas the number of binding sites was unaffected by the nucleotide (Bmax = 0.2 pmol/mg protein). Analysis of dissociation kinetics demonstrated that in the absence of guanyl nucleotides, the rate of [125I-Tyr1]SRIF dissociation was first order (t 1/2 = 180 min). However, in the presence of a half-maximal concentration of guanyl-5'-yl-imidodiphosphate (0.3 microM), [125I-Tyr1]SRIF dissociation occurred with biphasic kinetics. Fifty percent of the specifically bound peptide dissociated at the same rate as that observed in the absence of nucleotide, whereas the remainder dissociated 15 times more rapidly (t 1/2 = 9.6 min).(ABSTRACT TRUNCATED AT 400 WORDS)
Insights
Somatostatin (SRIF) receptor binding is mediated by adenylate cyclase inhibition in pituitary tumor cells. Guanine nucleotides decrease SRIF receptor affinity, affecting dissociation kinetics and indicating receptor-mediated inhibition.
Area of Science:
- Endocrinology
- Cell Biology
- Molecular Pharmacology
Background:
- Somatostatin (SRIF) inhibits vasoactive intestinal peptide (VIP)-stimulated cAMP accumulation in GH4C1 rat pituitary tumor cells.
- This inhibition is crucial for SRIF's effect on VIP-stimulated hormone release.
Purpose of the Study:
- To investigate the interaction between the SRIF receptor and adenylate cyclase in GH4C1 cell membranes.
- To elucidate the mechanism of SRIF-mediated inhibition of VIP-stimulated adenylate cyclase activity.
Main Methods:
- Measurement of adenylate cyclase activity in GH4C1 cell membranes.
- Assessment of SRIF and analog potencies in inhibiting VIP-stimulated cAMP accumulation.
- Analysis of [125I-Tyr1]SRIF binding kinetics in the presence and absence of guanine nucleotides.
Main Results:
- SRIF noncompetitively inhibited VIP-stimulated adenylate cyclase activity without affecting basal activity.
- SRIF receptor binding affinity was reduced by guanine nucleotides (GTP, Gpp(NH)p), indicating receptor-mediated inhibition.
- Guanine nucleotides altered SRIF dissociation kinetics from biphasic to monophasic, suggesting a conformational change in the receptor-ligand complex.
Conclusions:
- SRIF inhibition of adenylate cyclase in GH4C1 cells is receptor-mediated.
- Guanine nucleotides play a critical role in modulating SRIF receptor affinity and dissociation kinetics.
- These findings provide insights into the molecular mechanisms of somatostatin receptor signaling.